Fluence is a pioneering company in the field of psychedelic-assisted therapy and psychedelic integration therapy training, offering a range of continuing education programs. Founded in 2019 and headquartered in the United States, the company focuses on providing licensed professionals and advanced graduate students with the opportunity to work with patient populations. Their interactive programs, which include discussions, demonstrations, self-reflection exercises, and role plays, are open to not just clinicians but all individuals interested in participating. The company recently secured a significant $1.40M in Seed Round investment from a group of prominent investors including Evolve Ventures, LearnStart, Baroda Ventures, Iter Investments, Matthew Emerson, Noah Levy, and Michael Cotton.
General Information
Get notified when Fluence moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Fluence
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
United States Market
About Fluence
Taxonomy: Psychedelic-assisted therapy, Psychedelic integration therapy, Continuing education programs, Healthcare professionals, Licensed professionals, Graduate students, Mental health field, Psychotherapy, Interactive programs, Self-reflection exercises, Role plays, Open policy, Clinicians, Patient populations, Professional development
Funding Rounds & Investors (2)
View AllFluence Alternatives & Competitors
ATMA provides Psychedelic-assisted Therapy Training and Clinics for practitioners and students
Creating Access to Psychedelic Therapy Through Affordable, Safe At-Home Ketamine Assisted Therapy
Connecting military veterans w/ mental trauma to psychedelic therapy options: ayahuasca, psilocybin,...
FAQ About Fluence
Don't just browse. Track.
Signal Tracker monitors Fluence and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.